TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
HCM

HUTCHMED DRC

Healthcare · Drug Manufacturers - Specialty & Generic

13.70$ +0.0% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Income Statement

HUTCHMED DRC (HCM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 139 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Income Statement HCM
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
56 56 63 127 57 113 52 50 59 53 52 50 49 53 52 55 61 61 81 76 99 138 101 202 112 112 266 266 80 153 153 153 162 162 139 139 135 135 139 139 549
61 61 60 88 65 85 37 35 62 10 41 38 70 113 41 42 103 103 65 59 156 130 160 137 189 189 104 104 167 239 90 90 190 190 84 84 159 159 115 115 548
-5.0 -5.0 2.8 -5.6 -7.9 28 15 15 -3.1 43 11 12 -20 -61 10 13 -42 -42 17 18 -56 8.2 -59 65 -77 -77 162 162 -86 -86 63 63 -28 -28 55 55 -23 -23 24 24 1.1
17 17 16 32 22 43 29 31 0.6 56 33 36 31 93 31 43 51 112 57 66 88 104 91 182 105 105 72 72 79 79 48 48 59 59 36 36 41 41 39 39 162
5.8 5.8 6.0 53 6.0 6.0 7.0 7.5 7.4 8.9 10 8.6 11 26 9.7 12 14 17 17 20 26 54 29 58 17 17 21 21 19 5.8 15 15 17 17 14 14 19 19 16 16 71
10 10 11 143 11 11 40 44 12 67 47 48 16 138 43 59 -81 -81 80 98 36 300 40 399 28 28 106 106 -40 -40 77 77 -20 -20 57 57 -5.3 -5.3 23 23 36
-15 -15 -8.0 16 -19 -19 -25 -29 -15 -24 -36 -36 -42 101 -32 -46 39 39 -63 -81 -92 203 -98 -334 -105 -105 56 56 -47 -47 -14 -14 -8.1 -8.1 -1.8 -1.8 -18 -18 0.4 0.4 -35
1.6 0.8 0.4 0.8 1.1 0.6 0.3 0.2 0.3 0.3 1.8 12 0.1 1.0 17 13 – 0.1 24 19 – 0.5 – – – 0.5 – – – – – – – – – – – – – – –
7.2 7.2 -17 5.5 -13 -13 -8.8 -19 -25 -15 -18 -23 -31 -46 -14 -32 -32 -32 -38 -60 -29 -43 -84 -167 -97 -97 86 86 -33 -33 15 15 8.2 8.2 259 259 1.3 1.3 8.7 8.7 20
1.3 1.3 0.9 1.8 0.6 0.6 1.6 1.1 0.3 1.0 1.3 1.2 0.1 -41 1.0 1.0 1.4 1.4 1.9 -0.1 5.0 -52 -2.1 -4.2 2.0 2.0 1.4 1.4 0.9 0.9 1.4 1.4 2.2 2.2 32 32 0.2 0.2 0.6 0.6 1.7
5.6 5.6 0.8 1.7 -14 -28 -12 -21 -26 -44 -20 -25 -31 -37 -16 -34 -38 -38 -41 -62 -46 -27 -81 -163 -99 -99 84 84 -34 -34 13 13 6.0 6.0 227 227 1.0 1.0 8.0 8.0 18
-15 -15 -7.4 -18 -18 -17 -24 -28 -14 -23 -35 -35 -35 101 -31 -46 -58 -58 -63 -81 -90 -81 -96 -167 -103 -103 58 58 -44 -44 -11 -11 -5.0 -5.0 1.3 1.3 -14 -14 4.0 4.0 -21

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?